Depressiveness, symptoms of anxiety and cognitive dysfunctions in patients with asthma and chronic obstructive pulmonary disease (COPD): possible associations with inflammation markers: a pilot study

Journal of Neural Transmission

Volumn 122, Issue , 2015, Pages 83-91

  Bratek, Agnieszka ^a   Zawada, Karolina ^a   Beil Gawełczyk, Julia ^b   Beil, Sonia ^a   Sozańska, Ewa ^a   Krysta, Krzysztof ^a   Barczyk, Adam ^a   Krupka Matuszczyk, Irena ^a   Pierzchała, Władysław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Ward of Endocrinology and Diabetology   (Poland)

Author keywords

Anxiety; Asthma; Comorbidity; COPD; Depression; Psychiatry; Psychosomatics; Pulmonology

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; ASTHMA; BECK DEPRESSION INVENTORY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INFLAMMATORY INFILTRATE; LYMPHOCYTE; MACROPHAGE; MALE; MEDICAL HISTORY; MENTAL HEALTH CARE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NEUTROPHIL; PILOT STUDY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SMOKING; STATE TRAIT ANXIETY INVENTORY; ANXIETY DISORDERS; ASTHENIA; COGNITION DISORDERS; COMPLICATION; MIDDLE AGED; NONPARAMETRIC TEST; PSYCHOLOGICAL RATING SCALE; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ANXIETY DISORDERS; ASTHENIA; COGNITION DISORDERS; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 84938955882     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-014-1171-9     Document Type: Article

References (68)

1. Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, Ayala AR, Licinio J, Gold HK, Kling MA, Chrousos GP, Gold PW (2005) Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 90:2522–2530
2. Antony MM, Orsillo SM, Roemer L (2001) Practitioner’s guide to empirically based measures of anxiety. Kluwer Academic/Plenum Publishers, New York
3. Asnaashari AM, Talaei A, Haghigh B (2012) Evaluation of psychological status in patients with asthma and COPD. Iran J Allergy Asthma Immunol 11(1):65–71. doi:http://www.ncbi.nlm.nih.gov/pubmed/22427478
4. Balcells E, Gea J, Ferrer J, Serra I, Orozco-Levi M, de Batlle J, Rodriguez E, Benet M, Donaire-González D, Antó JM, Garcia-Aymerich J; PAC-COPD Study Group (2010) Factors affecting the relationship between psychological status and quality of life in COPD patients. Health Qual Life Outcomes 8:108. doi:10.1186/1477-7525-8-108
5. Barnes PJ, Drazen JM, Rennard SI, Thomson NC (2002) Asthma and COPD: basic mechanisms and clinical management. Academic Press, London
6. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
7. Bratek A, Zawada K, Barczyk A, Sozańska E, Krysta K (2013) Analysis of psychoemotional state and intellectual abilities in patients with asthma and chronic obstructive pulmonary disease-preliminary results. Psychiatr Danub 25(Suppl 2):207–211
8. Brenes GA (2003) Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med 2003(65):963–970
9. Brown ES (2009) Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann N Y Acad Sci 1179:41–55. doi:10.1111/j.1749-6632.2009.04981.x
10. Brown ES, Vera E, Frol AB, Woolston DJ, Johnson B (2007) Effects of chronic prednisone therapy on mood and memory. J Affect Disord 99:279–283
11. Caldera-Alvarado G, Khan DA, Defina LF, Pieper A, Brown ES (2013) Relationship between asthma and cognition: the Cooper Center Longitudinal Study. Allergy 68(4):545–548. doi:10.1111/all.12125
12. Carvalho NS, Ribeiro PR, Ribeiro M, Nunes MP, Cukier A, Stelmach R (2007) Comparing asthma and chronic obstructive pulmonary disease in terms of symptoms of anxiety and depression. J Bras Pneumol 33(1):1–6
13. Corrigan JD, Hinkeldey MS (1987) Relationships between parts A and B of the Trail Making Test. J Clin Psychol 43:402–409
14. Deshmukh VM, Toelle BG, Usherwood T, O’Grady B, Jenkins CR (2008) The association of comorbid anxiety and depression with asthma-related quality of life and symptom perception in adults. Respirology 13(5):695–702. doi:10.1111/j.1440-1843.2008.01310
15. Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, Allegra L, Centanni S (2006) Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 100:1767–1774
16. Doherty DE, Briggs DD (2004) Chronic obstructive pulmonary disease: epidemiology, pathogenesis, disease course, and prognosis. Clin Cornerstone Suppl 2:5–16
17. Dowson C, Laing R, Barraclough R, Town I, Mulder R, Norris K, Drennan C (2001) The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study. N Z Med J 114(1141):447–449
18. Doyle T, Palmer S, Johnson J, Babyak MA, Smith P, Mabe S, Welty-Wolf K, Martinu T, Blumenthal JA (2013) Association of anxiety and depression with pulmonary-specific symptoms in chronic obstructive pulmonary disease. JA Int J Psychiatry Med 45(2):189–202
19. Dróżdż W, Wojnar M, Araszkiewicz A, Nawacka-Pawlaczyk D, Urbański R, Cwiklińska-Jurkowska M, Rybakowski J (2007) The study of the prevalence of depressive disorders in primary care patients in Poland. Wiad Lek 60(3–4):109–113
20. Dudek D, Siwek M, Datka W, Wróbel A, Zieba A (2007) The evolution of depressive symptoms in coronary artery disease patients after successful coronary angioplasty. Psychiatr Pol 41(2):217–227
21. Ford DE, Erlinger TP (2004) Depression and C-reactive protein in US adults. Arch Intern Med 164:1010–1014
22. Gibson PG, Simpson JL (2009) The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 64:728–735. doi:10.1136/thx.2008.108027
23. Global initiative for chronic obstructive lung disease (2013) Global Strategy for the diagnosis, management and prevention of COPD. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf
24. Goodwin RD, Pagura J, Cox B, Sareen J (2010) Asthma and mental disorders in Canada: impact on functional impairment and mental health service use. J Psychosom Res 68(2):165–173. doi:10.1016/j.jpsychores.2009.06.005
25. Goodwin RD, Lavoie KL, Lemeshow AR, Jenkins E, Brown ES, Fedoronko DA (2012) Depression, anxiety, and COPD: the unexamined role of nicotine dependence. Nicotine Tob Res 14(2):176–183. doi:10.1093/ntr/ntr165
26. Hanania NA, Müllerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EF, Rennard SI, Sharafkhaneh A, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investigators (2011) Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 183(5):604–611. doi:10.1164/rccm.201003-0472OC
27. Hashmi AM, Butt Z, Umair M (2013) Is depression an inflammatory condition? A review of available evidence. J Pak Med Assoc 63(7):899–906
28. Hasler G, Gergen PJ, Kleinbaum DG, Ajdacic V, Gamma A, Eich D, Rössler W, Angst J (2005) Asthma and panic in young adults: a 20-year prospective community study. Am J Respir Crit Care Med 171:1224–1230
29. Hopkins SJ, Rothwell NJ (1995) Cytokines and the nervous system. Expression and recognition. Trends Neurosci 18:83–88
30. Institute for Health Metrics and Evaluation (2013) The global burden of disease: generating evidence, guiding policy. IHME, Seattle
31. Klein M, Gauggel S, Sachs G, Pohl W (2010) Impact of chronic obstructive pulmonary disease (COPD) on attention functions. Respir Med 104:52–60
32. Kozora E, Filley CM, Julian LJ, Cullum CM (1999) Cognitive functioning in patients with chronic obstructive pulmonary disease and mild hypoxemia compared with patients with mild Alzheimer disease and normal controls. Neuropsychiatry Neuropsychol Behav Neurol 12(3):178–183
33. Krishnadas R, Cavanagh J (2012) Depression: an inflammatory illness? J Neurol Neurosurg Psychiatry 83:495–502. doi:10.1136/jnnp-2011-301779
34. Kühl K, Schürmann W, Rief W (2008) Mental disorders and quality of life in COPD patients and their spouses. Int J Chron Obstruct Pulmon Dis 3(4):727–736
35. Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, Stanley MA (2005) Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 127:1205–1211
36. Lavoie KL, Cartier A, Labrecque M, Bacon SL, Lemière C, Malo JL, Lacoste G, Barone S, Verrier P, Ditto B (2005) Are psychiatric disorders associated with worse asthma control and quality of life in asthma patients? Respir Med 99:1249–1257
37. Lavoie KL, Bacon SL, Barone S, Cartier A, Ditto B, Labrecque M (2006) What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both? Chest 130(4):1039–1047. doi:10.1378/chest.130.4.1039
38. Lichtblau N, Schmidt FM, Schumann R, Kirkby KC, Himmerich H (2013) Cytokines as biomarkers in depressive disorder: current standing and prospects. Int Rev Psychiatry 25(5):592–603. doi:10.3109/09540261.2013.813442
39. Liesker JJ, Postma DS, Beukema RJ, ten Hacken NH, van der Molen T, Riemersma RA, van Zomeren EH, Kerstjens HA (2004) Cognitive performance in patients with COPD. Respir Med 98(4):351–356
40. MacNee W, ZuWallack RL, Keenan J (2009) Clinical management of chronic obstructive pulmonary disease, 3rd edn. Proffesional Communications, Caddo
41. Maes M (1999) Major depression and activation of the inflammatory response system. Adv Exp Med Biol 461:25–46
42. Martínez-Rivera C, Vennera Mdel C, Cañete C, Bardagí S, Picado C (2011) Psychological profile of patients with bronchial asthma and functional dyspnea: a comparison with a non-asthmatic population and impact on the disease. Arch Bronconeumol 47(2):73–78. doi:10.1016/j.arbres.2010.10.003
43. Masoli M, Fabian D, Holt S, Beasley R, Global Initiative for Asthma GINA Program (2004) The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy 59(5):469–478. doi:10.1111/j.1398-9995.2004.00526.x
44. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA (2008) Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 134:43–56. doi:10.1378/chest.08-0342
45. Nowobilski R, Furgał M, Czyz P, De Barbaro B, Polczyk R, Bochenek G, Nizankowska-Mogilnicka E, Szczeklik A (2006) Psychopathology and personality factors modify the perception of dyspnea in asthmatics. J Asthma 44(3):203–207. doi:10.1080/02770900701209772
46. Nowobilski R, Furgał M, Czyz P, De Barbaro B, Polczyk R, Bochenek G, Nizankowska-Mogilnicka E, Szczeklik A (2007) Psychopathology and personality factors modify the perception of dyspnea in asthmatics. J Asthma 44(3):203–207
47. Nowobilski R, Furgał M, Polczyk R, de Barbaro B, Szczeklik A (2011) Gender gap in psychogenic factors may affect perception of asthma symptoms. J Investig Allergol Clin Immunol 21(3):193–198
48. O’Donovan A, Hughes BM, Slavich GM, Lynch L, Cronin MT, O’Farrelly C, Malone KM (2010) Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion-biology relationships. Brain Behav Immun 24:1074–1077
49. Omachi TA, Katz PP, Yelin EH, Gregorich SE, Iribarren C, Blanc PD, Eisner MD (2009) Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med 122(8):778. doi:10.1016/j.amjmed.2009.01.036
50. Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanović R, Maestrelli P, Sterk PJ (2002) Sputum induction. Eur Respir J Suppl 37:3–8
51. Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27:24–31
52. Rietveld S, Creer TL (2003) Psychiatric factors in asthma: implications for diagnosis and therapy. Am J Respir Med 2(1):1–10
53. Saetta M, Di Stefano A, Maestrelli P, Turato G, Ruggieri MP, Roggeri A, Calcagni P, Mapp CE, Ciaccia A, Fabbri LM (1994) Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 150(6):1646–1652
54. Salim S, Chugh G, Asghar M (2012) Inflammation in Anxiety. Adv Protein Chem Struct Biol 88:2–17
55. Schou L, Østergaard B, Rasmussen LS, Rydahl-Hansen S, Phanareth K (2012) Cognitive dysfunction in patients with chronic obstructive pulmonary disease-a systematic review. Respir Med 8:1071–1081. doi:10.1016/j.rmed.2012.03.013
56. Schraa JC, Dirks JF, Jones NF, Kinsman RA (1981) Bender-Gestalt performance and recall in an asthmatic sample. J Asthma 18(1):7–9
57. Scott KM, Von Korff M, Ormel J, Zhang MY, Bruffaerts R, Alonso J, Kessler RC, Tachimori H, Karam E, Levinson D, Bromet EJ, Posada-Villa J, Gasquet I, Angermeyer MC, Borges G, de Girolamo G, Herman A, Haro JM (2007) Mental disorder among adults with asthma: results from the World Mental Health Survey. Gen Hosp Psychiatry 29(2):123–133. doi:10.1016/j.genhosppsych.2006.12.006
58. Służewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K (1995) Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci 762:474–476
59. Speilberger CD, Sarason IG (1975) Stress and anxiety, vol 1. Hemisphere, Washington
60. Trzcińska H, Przybylski G, Kozłowski B, Derdowski S (2012) Analysis of the relation between level of asthma control and depression and anxiety. Med Sci Monit 18(3):190–194
61. van Ede L, Yzermans CJ, Brouwer HJ (1999) Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax 54:688–692. doi:10.1136/thx.54.8.688
62. Wang G, Wang L, Szczepaniak WS, Xiong ZY, Wang L, Zhou T, Fu JJ, Liang BM, Yuan YR, Li T, Ji YL (2010) Psychological status in uncontrolled asthma is not related to airway hyper-responsiveness. J Asthma 47(1):93–99. doi:10.3109/02770900903331119
63. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, Martin RJ (1997) Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 156(3):737–743
64. Wilson DH, Appleton SL, Taylor AW, Tucker G, Ruffin RE, Wittert G, Hugo G, Goldney RD, Findlay C, Adams RJ (2010) Depression and obesity in adults with asthma: multiple comorbidities and management issues. Med J Aust 192(7):381–383
65. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B et al (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21(9):655–679
66. Wojnar M, Drózdz W, Araszkiewicz A, Szymański W, Nawacka-Pawlaczyk D, Urbański R (2003) Prevalence of depressive disorders among perimenopausal women seeking gynecological services. Psychiatr Pol 37(5):811–824
67. Yellowlees PM, Alpers JH, Bowden JJ, Bryant GD, Ruffin RE (1987) Psychiatric morbidity in patients with chronic airflow obstruction. Med J Aust 146:305–307
68. Yohannes AM, Baldwin R, Connolly MJ (2000) Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry 15:1090–1096